Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terri J Allen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Diabetes/Metabolism Research and Reviews|August 31, 2002
Haemodynamics in microvascular complications in type 1 diabetesRiccardo Candido, Terri J Allen
Nephrology (Carlton, Vic.)|May 15, 2007
Rodent models of streptozotocin-induced diabetic nephropathyGreg H Tesch, Terri J Allen
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 24, 2006
Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological inventionAnna C Calkin, Terri J Allen
Clinical Science (London, England : 1979)|July 1, 2016
Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular diseaseBryna S M Chow, Terri J Allen
Expert Review of Endocrinology & Metabolism|February 21, 2019
Linking diabetes and atherosclerosisRiccardo Candido, Stella Bernardi, Terri J Allen
Current Protocols in Mouse Biology|June 13, 2015
Mouse Models for Studying Diabetic NephropathyBryna S M Chow, Terri J Allen
Atherosclerosis|September 26, 2006
A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient miceAkihiko Fujii, Terri J Allen, Paul J Nestel
Current Diabetes Reports|November 13, 2004
Use of genetic mouse models in the study of diabetic nephropathyTerri J Allen, Mark E Cooper, Hui Y Lan
Current Atherosclerosis Reports|April 8, 2004
Use of genetic mouse models in the study of diabetic nephropathyTerri J Allen, Mark E Cooper, Hui Y Lan
Annals of the New York Academy of Sciences|July 23, 2005
Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studiesKarin A Jandeleit-Dahm, Markus Lassila, Terri J Allen
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Diabetes/Metabolism Research and Reviews|August 31, 2002
Haemodynamics in microvascular complications in type 1 diabetesRiccardo Candido, Terri J Allen
Nephrology (Carlton, Vic.)|May 15, 2007
Rodent models of streptozotocin-induced diabetic nephropathyGreg H Tesch, Terri J Allen
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 24, 2006
Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological inventionAnna C Calkin, Terri J Allen
Clinical Science (London, England : 1979)|July 1, 2016
Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular diseaseBryna S M Chow, Terri J Allen
Expert Review of Endocrinology & Metabolism|February 21, 2019
Linking diabetes and atherosclerosisRiccardo Candido, Stella Bernardi, Terri J Allen
Current Protocols in Mouse Biology|June 13, 2015
Mouse Models for Studying Diabetic NephropathyBryna S M Chow, Terri J Allen
Atherosclerosis|September 26, 2006
A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient miceAkihiko Fujii, Terri J Allen, Paul J Nestel
Current Diabetes Reports|November 13, 2004
Use of genetic mouse models in the study of diabetic nephropathyTerri J Allen, Mark E Cooper, Hui Y Lan
Current Atherosclerosis Reports|April 8, 2004
Use of genetic mouse models in the study of diabetic nephropathyTerri J Allen, Mark E Cooper, Hui Y Lan
Annals of the New York Academy of Sciences|July 23, 2005
Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studiesKarin A Jandeleit-Dahm, Markus Lassila, Terri J Allen
Pageof 4